RE:RE:Plan XManglements decision to follow a high risk plan was not without a strategic option in mind.
yes, submitting a decade old phase 3a was rather stupid but you could tell they had a doomsday scenario in mind too. They raised money early in case of failure. They allude to the possiblities by stating that the market is really good for acquistions. This would be beaten down small biotechs- ones just like them but have no cash. So expect a merger with another oncology company with a real platform.
Meanwhile the reverse split is on hold because we have nothing to go to the USeless markets just now. First we have to fire our marketiing experts bought at great cost.